Form 4: Coliseum Capital Sells 2.48 Million Shares of Universal Technical Institute
SEC Form 4 Filing
Coliseum Capital Management, LLC, along with related entities and individuals, sold 2,483,579 shares of Universal Technical Institute (UTI) common stock at a price of $25.10 per share on December 2, 2024.
Summary
- Coliseum Capital Management, LLC, and related parties, including Christopher Shackelton, Adam Gray, Coliseum Capital, LLC, and Coliseum Capital Partners, L.P., reported a sale of 2,483,579 shares of Universal Technical Institute (UTI) common stock.
- The sale occurred on December 2, 2024, at a price of $25.10 per share.
- Following the transaction, Coliseum Capital and related entities still beneficially own 6,850,636 shares of UTI common stock.
- The shares are held indirectly through Coliseum Capital Partners, L.P. and a separate account investment advisory client of Coliseum Capital Management, LLC.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock sale. While the sale itself could be seen as slightly negative, the filing is a standard procedure and doesn't inherently indicate a positive or negative outlook.
Negatives
- The sale of a significant number of shares by a major shareholder could be perceived negatively by the market.
Risks
- The sale by Coliseum Capital could indicate a change in their investment outlook for UTI.
- The market may react negatively to the sale, potentially impacting the share price.
Industry Context
This transaction is a standard SEC Form 4 filing, which is required when insiders or major shareholders of a publicly traded company buy or sell shares. It provides transparency into the trading activities of those with significant influence over the company.
Comparison to Industry Standards
- SEC Form 4 filings are a common occurrence for publicly traded companies, and this transaction is consistent with standard reporting practices.
- The sale of shares by a major shareholder is not unusual, but the market reaction can vary depending on the company and the context of the sale.
Stakeholder Impact
- The sale of shares could potentially impact the share price, affecting shareholders.
- The transaction may be of interest to other stakeholders, such as employees and creditors, as it provides insight into the actions of a major shareholder.
Key Dates
| Date | Description |
|---|---|
| 12/02/2024 | Date of the stock sale transaction. |
| 12/03/2024 | Date of filing the SEC Form 4. |
Keywords
Coliseum Capital, Universal Technical Institute, UTI, share sale, insider trading, beneficial ownership, stock transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.